Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Heritability of cerebral glutamate levels and their association with schizophrenia spectrum disorders: a 1[H]-spectroscopy twin study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. In Memoriam: Arvid Carlsson-Pioneering Researcher and Nobel Laureate

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Emotion recognition latency, but not accuracy, relates to real life functioning in individuals at ultra-high risk for psychosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Effects of clonidine on MMN and P3a amplitude in schizophrenia patients on stable medication

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Research findings implicate cerebral glutamate in the pathophysiology of schizophrenia, including genetic studies reporting associations with glutamatergic neurotransmission. The extent to which aberrant glutamate levels can be explained by genetic factors is unknown, and if glutamate can serve as a marker of genetic susceptibility for schizophrenia remains to be established. We investigated the heritability of cerebral glutamate levels and whether a potential association with schizophrenia spectrum disorders could be explained by genetic factors. Twenty-three monozygotic (MZ) and 20 dizygotic (DZ) proband pairs con- or discordant for schizophrenia spectrum disorders, along with healthy control pairs (MZ = 28, DZ = 18) were recruited via the National Danish Twin Register and the Psychiatric Central Register (17 additional twins were scanned without their siblings). Glutamate levels in the left thalamus and the anterior cingulate cortex (ACC) were measured using 1[H]-magnetic resonance spectroscopy at 3 Tesla and analyzed by structural equation modeling. Glutamate levels in the left thalamus were heritable and positively correlated with liability for schizophrenia spectrum disorders (phenotypic correlation, 0.16, [0.02-0.29]; p = 0.010). The correlation was explained by common genes influencing both the levels of glutamate and liability for schizophrenia spectrum disorders. In the ACC, glutamate and glx levels were heritable, but not correlated to disease liability. Increases in thalamic glutamate levels found in schizophrenia spectrum disorders are explained by genetic influences related to the disease, and as such the measure could be a potential marker of genetic susceptibility, useful in early detection and stratification of patients with psychosis.

OriginalsprogEngelsk
Artikelnummer44
TidsskriftNeuropsychopharmacology
Vol/bind44
Udgave nummer3
Sider (fra-til)581-9
Antal sider9
ISSN0893-133X
DOI
StatusUdgivet - feb. 2019

ID: 55553258